Table 2.
Patient characteristics
| n = 196 (%); median | range | |
|---|---|---|
| Sex | ||
| female | 73 (37.1) | |
| male | 123 (62.9) | |
| Medically inoperable | 182 (92.8) | |
| Medically operable | 14 (7.2) | |
| Localization | ||
| -central | 83 (42.3) | |
| -peripheral | 113 (57.7) | |
| Side | ||
| -left | 86 (43.9) | |
| -right | 110 (56.1) | |
| Grading (G) | ||
| G1 | 7 (3.6) | |
| G2 | 74 (37.8) | |
| G3 | 42 (21.4) | |
| Stage according to UICC (7th edition) | ||
| -I | 113 (57.7) | |
| -II | 68 (34.6) | |
| -IIIa | 15 (7.7) | |
| Histology | ||
| -Adenocarcinoma | 49 (39.9) | |
| -Squamous cell carcinoma | 71 (57.7) | |
| -Large cell carcinoma | 3 (2.4) | |
| -No biopsy due to comorbidities | 73 (37.2) | |
| Age | 67 | 29–86 |
| 0–50 | 6 (3.1) | |
| 50–65 | 63 (32.1) | |
| 66–80 | 101 (51.5) | |
| > 80 | 26 (13.3) | |
| aCCI | 7 | 3–16 |
| 0–3 | 4 (2.0) | |
| 4–6 | 63 (32.1) | |
| 7–9 | 62 (31.6) | |
| 10–12 | 44 (22.4) | |
| > 12 | 23 (11.9) | |
| Hypertension | 119 (60.7) | |
| Diabetes with or without end-organ damage | 52 (26.6) | |
| Moderate/severe renal damage | 63 (32.1) | |
| COPD | 167 (85.2) | |
| -Gold 1 + 2 | 51 (26.0) | |
| -Gold 3 | 61 (31.1) | |
| -Gold 4 | 55 (28.1) | |
| Peripheral vascular disease | 49 (25) | |
| Myocardial infarction | 31 (15.8) | |
| Congestive heart failure | 71 (36.2) | |
| Cerebral vascular disease | 13 (6.6) | |
| Mild liver disease | 9 (4.5) | |
| Isocenter Dose | ||
| -peripheral tumor | 18.75 | 18–20 |
| -central tumor | 7.5 | 7–9 |
| Packyears | 40 | 0–120 |